Brenda SnowAuthentic Patient Voice
Matt TurnerPatient Affordability
Bud BilanichSuccess Coach
Amy GilesIncreasing Engagement
Joey CohenMedication Adherence
Paul TheisenPatient Acquisition
David LinetskyPoint-of-Care Marketing
Stacey GandlerBrand Nourishment
Liz KaneImpactful Strategy
Matthew DurhamOmnidynamic Marketing
Frank BurrellScientific Storytelling
Suma Ramadas, PhDMedical Affairs
Daniel SontupeMarket Access
Pat PurcellMeeting Engagement
PURCHASE, NY, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE:TDOC) (“Teladoc”) today announced the ...
Study met its primary endpoint with TG-1101 (ublituximab) plus ibrutinib increasing Overall Response Rate ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email